Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",26833,124,0.63 [0.43-0.93],0.0196108952997699
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27590,209,1.13 [0.84-1.51],0.4274850857000002
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27304,1350,0.96 [0.85-1.07],0.4484664418899978
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Candidiasis,27614,477,1.08 [0.89-1.31],0.4382490632040193
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26754,3537,1.04 [0.97-1.12],0.314619940761466
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),26984,2918,1.06 [0.98-1.15],0.1225835446216261
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27323,1387,1.15 [1.03-1.29],0.0152160663292533
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27509,93,1.13 [0.73-1.76],0.5755033808567974
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25730,829,1.17 [1.01-1.36],0.0382955581458953
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24891,971,1.11 [0.97-1.28],0.1199362800237022
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,24908,265,1.09 [0.84-1.41],0.5354650095289227
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19376,1698,1.05 [0.95-1.17],0.3212613302678913
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24665,376,1.23 [0.99-1.53],0.0610382334520954
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27554,1618,1.12 [1.01-1.25],0.0299623927173342
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Mycoses,27680,543,1.00 [0.83-1.21],0.974349238334406
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26913,959,0.98 [0.85-1.12],0.7475333054506754
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27624,915,1.06 [0.92-1.22],0.3902542321415307
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26145,209,1.14 [0.85-1.52],0.3909938666984871
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27743,46,1.45 [0.78-2.71],0.2362498490813697
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27510,801,1.15 [0.99-1.33],0.0716407033438601
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27500,84,1.09 [0.69-1.72],0.7174115700602897
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27647,198,1.19 [0.88-1.61],0.2554789118586127
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27628,179,1.19 [0.86-1.63],0.2951299028579918
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26301,347,1.04 [0.83-1.31],0.7361389102026754
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26219,265,0.83 [0.64-1.08],0.1683822172215904
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26066,130,1.13 [0.78-1.63],0.5233354251148152
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27721,37,2.00 [1.05-3.82],0.0358076444698187
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27665,161,1.05 [0.75-1.47],0.7846881630123547
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral warts,27553,49,1.13 [0.62-2.09],0.6846923979807484
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27582,78,1.02 [0.63-1.66],0.932557858855987
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm,27474,245,0.86 [0.65-1.12],0.2632412595997756
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27641,72,0.97 [0.58-1.61],0.9094651940148168
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27635,71,1.14 [0.69-1.87],0.6138724024982664
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27450,1251,0.85 [0.75-0.96],0.0087252008776113
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of meninges,27716,82,0.96 [0.60-1.55],0.8812660506751727
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27674,66,0.49 [0.28-0.84],0.0093014045573408
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27709,138,1.00 [0.70-1.43],0.9897664459962005
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of ovary,27660,178,1.31 [0.95-1.80],0.0980161080618576
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27722,286,0.88 [0.68-1.13],0.3117720194670302
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Caecum,27727,256,0.80 [0.61-1.05],0.1068240729830174
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27653,65,0.83 [0.49-1.41],0.496951328976264
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Descending colon,27724,158,0.74 [0.53-1.05],0.0881969814001739
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Rectum,27685,288,0.92 [0.72-1.19],0.5420606920075052
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27635,508,0.90 [0.74-1.09],0.2867471554411932
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27722,304,0.69 [0.54-0.88],0.003050641673599
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Carcinoma in situ of breast,22467,140,1.13 [0.78-1.64],0.5118622924343477
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22557,169,1.16 [0.83-1.62],0.3953544656939957
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22537,32,0.78 [0.36-1.69],0.524448176174665
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22573,68,1.27 [0.76-2.13],0.3660472929655165
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27675,139,0.87 [0.60-1.26],0.4520209722211101
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma, any site",27676,137,0.87 [0.60-1.27],0.4759974073644027
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Leiomyoma of uterus,26743,585,0.85 [0.71-1.02],0.0805817100098179
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Lung cancer and mesothelioma,19908,316,0.68 [0.53-0.88],0.003099327243268
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Lymphoid leukaemia,22542,37,0.66 [0.32-1.37],0.2628920966459369
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22681,176,1.00 [0.72-1.40],0.9899859551975664
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22620,115,0.90 [0.60-1.35],0.619724310037408
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22694,189,1.17 [0.85-1.60],0.3411155705275283
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22577,72,1.68 [1.02-2.78],0.0425328187263629
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22576,71,0.81 [0.48-1.35],0.420724478283249
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22563,58,0.98 [0.55-1.72],0.9341941282268272
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22649,144,1.42 [1.00-2.02],0.0513143172271165
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22609,104,1.01 [0.67-1.54],0.9561742691858844
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22590,85,0.85 [0.53-1.37],0.5007081247109317
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22548,43,0.90 [0.46-1.74],0.7535016158547494
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22587,82,1.01 [0.62-1.65],0.9593281262591876
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi,27475,231,0.89 [0.67-1.19],0.4362426876479442
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi of trunk,27694,81,0.63 [0.38-1.03],0.0637856865851778
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanoma in situ,22540,89,0.98 [0.61-1.56],0.928288501672165
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22588,83,1.13 [0.71-1.81],0.6136723345876092
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22660,155,1.08 [0.76-1.52],0.6748120498299213
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",22734,229,0.69 [0.52-0.91],0.0085499078436737
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22602,97,1.19 [0.77-1.85],0.4289307817194753
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Other benign neoplasms of skin,27511,165,0.93 [0.66-1.30],0.6642228934040529
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23452,947,1.14 [0.99-1.32],0.061324623566619
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23492,987,1.14 [0.99-1.31],0.0615618247494939
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27430,381,1.16 [0.93-1.44],0.1927701754254279
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,25686,107,3.36 [2.31-4.89],2.1057885153573903e-10
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27121,72,0.84 [0.51-1.38],0.4891867303801648
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26716,3028,1.12 [1.03-1.21],0.0062067910071179
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26076,37,1.09 [0.54-2.18],0.8113149408102066
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27329,49,0.62 [0.33-1.14],0.1258457714323419
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27147,1568,1.23 [1.11-1.37],0.0001232548850506
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27147,1568,1.23 [1.11-1.37],0.0001232548850506
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25651,72,1.95 [1.19-3.21],0.0084779716694831
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27328,1289,1.15 [1.02-1.29],0.022971019975439
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27404,124,1.07 [0.73-1.58],0.715825918626519
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27101,52,1.08 [0.60-1.94],0.793922182755231
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27106,57,0.97 [0.56-1.68],0.9059736476154104
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27523,243,1.17 [0.89-1.54],0.2509030955681797
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27628,63,0.36 [0.21-0.63],0.0003044168988265
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27486,206,1.28 [0.95-1.71],0.1078185013255844
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26176,137,0.93 [0.64-1.34],0.680560702678697
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,22317,260,1.24 [0.95-1.62],0.1146689318455947
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26295,70,0.43 [0.25-0.72],0.0014936654435234
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26292,67,0.69 [0.51-0.93],0.0141631104334645
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,22110,53,0.39 [0.21-0.72],0.0026807642588302
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25437,70,0.71 [0.42-1.19],0.1942115780022832
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25070,250,1.12 [0.86-1.47],0.4030317671066762
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27296,511,1.00 [0.83-1.21],0.9891889789237918
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27078,293,0.79 [0.61-1.02],0.0721530645691145
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,26872,87,0.74 [0.46-1.18],0.2026233633882857
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27338,1971,0.90 [0.82-1.00],0.0454746937859247
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24543,1921,0.90 [0.81-0.99],0.0328566138493833
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",22117,60,1.65 [0.94-2.88],0.0802904757874339
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24602,120,1.56 [1.06-2.30],0.0235915985261859
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,22345,288,1.02 [0.79-1.32],0.859812329824518
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,22105,48,0.57 [0.30-1.09],0.0880503776283375
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,25245,3188,0.99 [0.92-1.07],0.8258726117313023
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,22264,207,1.54 [1.14-2.08],0.0044966726674144
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22604,547,1.14 [0.94-1.37],0.1764215607200202
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27637,376,1.32 [1.06-1.64],0.0139329460490567
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27447,186,1.62 [1.19-2.19],0.0021348856016678
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,22159,102,0.97 [0.63-1.50],0.888052637659275
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",22112,55,1.44 [0.80-2.58],0.226423732067695
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26838,2356,1.12 [1.03-1.22],0.0117849590625464
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,22271,214,2.18 [1.64-2.91],1.0716303383839537e-07
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,22276,219,2.47 [1.88-3.25],7.858117065852263e-11
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22597,540,1.03 [0.85-1.24],0.7834186955797257
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,22152,95,1.01 [0.65-1.58],0.9586800862518396
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27437,176,1.63 [1.19-2.23],0.0024669565539144
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22694,637,1.01 [0.85-1.20],0.947214862036308
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22631,574,0.92 [0.77-1.11],0.3707906112322271
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,24890,70,1.37 [0.83-2.28],0.2213319636608899
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26827,4770,1.00 [0.94-1.07],0.9652067280242927
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24560,78,1.01 [0.62-1.63],0.9749768665933236
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24570,88,1.26 [0.79-1.99],0.3364423430068133
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27541,2107,0.96 [0.88-1.05],0.3964856012614892
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27546,2106,0.96 [0.88-1.06],0.4329745840333954
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24562,80,1.32 [0.82-2.12],0.2512324622287253
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27328,1607,0.96 [0.86-1.07],0.4429262136470636
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23610,1553,1.07 [0.96-1.20],0.2070884730939177
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27729,186,1.04 [0.77-1.41],0.806485011622388
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,26843,58,0.96 [0.55-1.67],0.8751450179601806
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,25854,133,1.23 [0.85-1.78],0.2686402763812189
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,25921,200,0.79 [0.58-1.07],0.1306265914625523
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",22330,273,1.04 [0.79-1.36],0.7913881470722413
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25893,144,1.03 [0.72-1.47],0.8582344932598196
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1725,49,1.28 [0.73-2.24],0.3917080655911318
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1840,186,1.07 [0.80-1.43],0.6613277749629911
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25774,25,0.60 [0.24-1.47],0.2593330051833684
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1707,32,2.51 [1.28-4.91],0.0074122826970598
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27248,1499,0.85 [0.76-0.95],0.0033582540946953
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27131,346,0.86 [0.68-1.08],0.2031506217260296
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25313,493,1.01 [0.84-1.22],0.912024923839646
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22801,744,1.07 [0.92-1.26],0.3789210552283717
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27642,233,1.00 [0.76-1.33],0.9736770686230268
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26717,57,0.64 [0.36-1.13],0.1212989376945063
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Angina pectoris,26188,900,1.07 [0.92-1.23],0.3782099114092745
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26762,102,0.98 [0.64-1.50],0.9278825604354748
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26693,33,0.95 [0.45-2.00],0.8892117347892956
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26813,153,0.84 [0.59-1.19],0.3261574563282461
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,18041,1515,1.12 [1.00-1.26],0.0453026396374109
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,AV-block,24273,248,0.95 [0.72-1.26],0.7357456289221442
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27699,310,1.22 [0.96-1.55],0.0993952704531496
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cardiac arrest,16658,132,1.46 [0.99-2.14],0.054571315464851
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24162,137,1.46 [1.01-2.10],0.0421812854453089
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",24105,80,1.48 [0.92-2.40],0.1065038906182853
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27738,34,1.51 [0.74-3.08],0.2599204687056777
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Conduction disorders,24769,744,1.15 [0.98-1.35],0.0826244254739077
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26815,1538,1.14 [1.02-1.27],0.0217735322649128
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,24943,7358,0.95 [0.90-1.00],0.0471745950193502
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26201,247,1.05 [0.80-1.38],0.7029196282653405
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Endocarditis,24088,63,1.79 [1.06-3.02],0.0306526115813148
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27643,869,1.13 [0.98-1.30],0.0960959222332851
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertension,25572,6222,0.91 [0.86-0.97],0.0014232191036444
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25584,6234,0.92 [0.87-0.97],0.0032294505120345
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27628,45,1.90 [1.04-3.47],0.0361188242782032
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19517,167,2.46 [1.78-3.39],4.073119656644317e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19455,105,4.92 [3.36-7.20],2.8652244255943063e-16
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypotension,27598,1128,1.13 [0.99-1.28],0.0613428072853523
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,26972,94,0.70 [0.44-1.09],0.1154703195542952
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27015,1727,1.12 [1.01-1.24],0.0336555203294663
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27422,465,1.27 [1.04-1.54],0.0178426999809791
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Left bundle-branch block,24327,302,1.29 [1.00-1.65],0.0473389215071865
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27515,616,0.99 [0.84-1.18],0.9263632727687566
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25783,495,1.10 [0.91-1.33],0.3430042931754746
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27716,88,0.95 [0.60-1.50],0.823635356254657
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27736,245,1.26 [0.96-1.65],0.0920577639010353
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Oesophageal varices,25993,39,1.04 [0.52-2.08],0.9034070936833584
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other aneurysm,26721,61,1.00 [0.57-1.74],0.9963227818526488
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other arrhythmias,24389,364,1.28 [1.02-1.61],0.0310216727794855
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26726,66,0.80 [0.47-1.35],0.3987378508567218
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26856,196,1.31 [0.97-1.77],0.0816772381112783
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,24184,159,1.23 [0.87-1.73],0.2380406285067851
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other disorders of veins,26050,96,1.05 [0.68-1.62],0.8273071417475455
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26000,46,1.24 [0.66-2.32],0.4971428288118483
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26470,39,0.81 [0.41-1.62],0.5546539578852823
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26120,166,1.19 [0.86-1.66],0.2960919431939802
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24851,826,1.15 [0.99-1.33],0.0723537989816534
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26513,43,1.80 [0.95-3.38],0.0692576658880202
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27168,508,1.05 [0.87-1.27],0.6329486297118696
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27161,324,1.33 [1.05-1.67],0.0157395027770988
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",26982,551,1.07 [0.89-1.28],0.4944828104810947
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16821,295,0.86 [0.66-1.12],0.2517303674077371
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26925,279,1.29 [1.00-1.66],0.0474152024960658
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26283,329,1.02 [0.80-1.29],0.881232772741638
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27285,448,1.00 [0.82-1.23],0.9725619323852672
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27662,599,1.14 [0.96-1.36],0.1264051316997218
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Right bundle-branch block,24253,228,1.14 [0.86-1.53],0.3626042690008291
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27153,316,1.28 [1.02-1.62],0.0357451025213396
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26596,165,1.22 [0.88-1.69],0.2379556831877262
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27415,537,1.17 [0.97-1.40],0.0996841347270426
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27389,585,1.15 [0.97-1.38],0.1086561310147813
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,26937,71,1.04 [0.63-1.73],0.8822474573716338
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26708,48,1.44 [0.77-2.68],0.2578641714321021
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27177,220,1.40 [1.05-1.86],0.0206356717987168
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27101,202,0.77 [0.57-1.03],0.0814871557499317
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Varicose veins,26420,466,1.11 [0.91-1.35],0.3110846268675436
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26672,97,1.03 [0.66-1.59],0.9105527706384844
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27528,709,1.01 [0.86-1.19],0.8606618552512926
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27695,223,0.51 [0.38-0.68],5.232059974936376e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24632,1875,0.95 [0.86-1.05],0.3077097224897426
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Any mental disorder,27125,4368,0.91 [0.86-0.98],0.0070126807709405
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27663,266,0.46 [0.35-0.61],2.1717649889082578e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24750,1993,0.89 [0.81-0.98],0.0231075474401091
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22850,93,0.76 [0.48-1.20],0.2369030411280462
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Smoking dependency,27323,1212,0.97 [0.86-1.10],0.6790430177802544
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24157,1400,0.88 [0.78-0.98],0.0239344298269411
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Vascular dementia,27230,102,0.97 [0.64-1.48],0.8965829266033815
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Alzheimer disease,27742,364,0.79 [0.63-0.99],0.0406469013098973
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",18922,60,1.06 [0.60-1.85],0.8493755439994397
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Bell's palsy,25559,87,1.25 [0.79-1.97],0.3334822255394951
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26113,641,0.89 [0.75-1.05],0.16450873392241
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Cerebral cysts,27326,220,1.39 [1.04-1.85],0.0253855270344352
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27668,283,1.31 [1.02-1.67],0.0354936707669949
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27252,40,0.73 [0.37-1.45],0.3640390138558411
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27729,47,1.37 [0.74-2.54],0.3171598790948191
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27160,54,1.38 [0.77-2.46],0.2804552712970453
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Epilepsy,26229,287,0.97 [0.75-1.26],0.8338217459483708
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27320,1378,1.14 [1.02-1.28],0.0239471234959437
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27692,520,0.92 [0.76-1.11],0.399377073719117
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27096,2937,0.93 [0.86-1.00],0.0621253520870887
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Generalized epilepsy,27367,47,0.56 [0.30-1.05],0.0696562534572413
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Hemiplegia,27612,227,1.57 [1.19-2.06],0.0012460845108758
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Hydrocephalus,27171,65,0.93 [0.54-1.58],0.7824483858551348
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27724,76,1.39 [0.85-2.25],0.1863628419863391
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25600,128,0.82 [0.55-1.20],0.3070203004359514
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,25540,68,0.72 [0.42-1.21],0.2130851125141397
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Memory loss,27103,97,0.66 [0.42-1.02],0.0640180052406393
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Migraine,26464,522,1.39 [1.15-1.68],0.0005552712190438
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27626,468,1.40 [1.15-1.71],0.0007689670568446
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Motor neuron disease,19009,121,1.08 [0.72-1.61],0.7187234773483697
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27522,142,1.53 [1.07-2.20],0.0206463079898396
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26881,1409,0.96 [0.86-1.08],0.489192818097787
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Neurological diseases,26107,3861,1.06 [0.99-1.14],0.0893532980848647
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27370,158,0.94 [0.67-1.32],0.7159876463437715
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25899,427,0.92 [0.74-1.13],0.4082586010064213
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27684,240,1.68 [1.29-2.20],0.000128203139932
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22327,670,0.92 [0.78-1.09],0.3374235454021727
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27176,70,0.70 [0.42-1.16],0.1671161329928465
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27231,125,1.07 [0.74-1.56],0.7132642379808258
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27360,188,1.08 [0.79-1.48],0.6149142800208881
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25568,96,1.27 [0.82-1.96],0.277461201178124
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other headache syndromes,26019,77,1.01 [0.62-1.64],0.9741552722149324
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other neurological diseases,27619,513,1.11 [0.92-1.35],0.2554261362952693
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other sleep disorders,26356,414,0.92 [0.74-1.13],0.411126849427424
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Parkinson's disease,27717,316,0.85 [0.67-1.08],0.1836459115266487
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27190,84,1.35 [0.85-2.16],0.2074132712786696
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Restless leg syndrome,27741,103,1.31 [0.86-1.98],0.2110154914504695
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Sleep apnoea,27560,327,0.87 [0.68-1.10],0.246627999881134
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27484,40,1.35 [0.69-2.65],0.3778870309456766
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27732,151,1.01 [0.71-1.44],0.941726895340432
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25538,66,1.76 [1.06-2.92],0.0292622709831612
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27742,368,0.78 [0.62-0.98],0.0296756527885499
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27186,99,1.01 [0.66-1.55],0.9676416315947108
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27154,112,1.56 [1.05-2.32],0.0280899729597628
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27266,487,0.95 [0.78-1.16],0.608106819083064
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27596,176,0.97 [0.71-1.32],0.8292127420269199
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26616,62,0.91 [0.52-1.58],0.7343842129234787
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26606,52,1.80 [1.00-3.25],0.0512115280356352
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27616,63,1.02 [0.60-1.75],0.930539989002824
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27454,167,1.14 [0.82-1.58],0.4449219030713316
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1713,37,1.99 [1.07-3.72],0.0306339268979307
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2062,71,1.22 [0.77-1.94],0.3903207770904158
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27137,95,0.94 [0.61-1.47],0.8016013724941646
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27560,1074,0.99 [0.87-1.13],0.8720719404156856
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27315,761,0.91 [0.78-1.07],0.2495013506868348
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26854,300,0.84 [0.65-1.07],0.1573430386656644
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27646,867,1.09 [0.94-1.27],0.2349266301705859
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27725,71,1.43 [0.87-2.35],0.1591733651348562
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27567,788,1.05 [0.90-1.22],0.5659376081711427
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27695,408,1.10 [0.89-1.35],0.3996957531818328
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27645,209,1.02 [0.76-1.37],0.8816714273024646
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26595,41,0.66 [0.33-1.31],0.2385869858521562
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26603,49,0.74 [0.40-1.39],0.3525082543569969
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26619,65,1.10 [0.65-1.87],0.7250569016632094
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27650,732,0.94 [0.80-1.10],0.4450123547266924
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27107,189,0.86 [0.63-1.17],0.3380317234767496
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,26847,68,0.61 [0.36-1.04],0.0679938038768221
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27390,103,0.84 [0.55-1.29],0.4305483497143917
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27601,314,1.17 [0.92-1.48],0.209977026371481
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,26995,216,1.26 [0.94-1.68],0.122333018509717
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27573,137,1.23 [0.86-1.77],0.2589212653978924
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27399,481,1.03 [0.84-1.25],0.7978959798406149
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27191,149,1.13 [0.80-1.59],0.4988267877069212
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,25927,2538,0.97 [0.89-1.05],0.4199616425922802
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27559,272,1.12 [0.87-1.45],0.3819104627158979
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27717,158,1.31 [0.93-1.83],0.11708131690467
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26952,398,0.87 [0.70-1.08],0.2031752150018087
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27350,63,0.88 [0.51-1.52],0.6557469698432207
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27710,56,1.46 [0.83-2.55],0.1859097955784753
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26644,90,1.20 [0.76-1.89],0.4254139272153269
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26710,156,0.91 [0.64-1.29],0.5908996873418555
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26596,110,1.17 [0.78-1.76],0.4496289009066034
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,26852,73,1.27 [0.77-2.11],0.3458852659014881
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26545,59,0.80 [0.45-1.40],0.4341821695142285
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27039,121,0.92 [0.62-1.35],0.6596132273000398
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27099,181,0.84 [0.61-1.15],0.2739390997659321
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26689,135,0.83 [0.57-1.20],0.3289046115962938
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26587,101,1.09 [0.70-1.68],0.7136894520018487
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26563,77,0.73 [0.45-1.20],0.2112971900821972
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25512,2123,1.00 [0.91-1.10],0.9896673591783408
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26640,86,0.95 [0.60-1.52],0.833078898494034
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27477,435,1.14 [0.93-1.40],0.2095329183041269
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27091,49,0.89 [0.49-1.63],0.7051377798215543
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27210,168,1.47 [1.07-2.03],0.0188252532365897
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27494,117,0.91 [0.61-1.35],0.6358129094368532
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27695,120,1.08 [0.73-1.59],0.7177383468578887
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27615,143,1.05 [0.73-1.50],0.7917156383700164
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27447,70,1.14 [0.68-1.91],0.6158896721593967
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,27450,73,1.41 [0.85-2.34],0.1812605386665712
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27640,821,0.97 [0.83-1.12],0.6491765635117173
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27381,562,1.00 [0.83-1.20],0.9921964788745612
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,26942,123,0.72 [0.49-1.05],0.0901155680201762
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,26907,88,0.90 [0.57-1.42],0.6459369081538275
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute pharyngitis,27465,87,1.10 [0.70-1.73],0.6892060760119644
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27616,238,0.98 [0.74-1.30],0.8995472984691436
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27444,66,1.13 [0.67-1.91],0.6420851009542571
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,All influenza,26000,128,1.15 [0.79-1.68],0.451799438423511
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),25998,126,1.11 [0.76-1.61],0.6021979789723277
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19722,130,0.82 [0.55-1.21],0.310010026703523
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Allergic rhinitis,27583,290,0.91 [0.70-1.18],0.4679910643904025
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21484,2083,0.93 [0.85-1.03],0.1528030906129026
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21648,2056,0.93 [0.85-1.03],0.173033038915926
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27320,124,1.11 [0.77-1.61],0.5807715172649708
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",25939,67,1.06 [0.64-1.77],0.8154862037691224
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Bronchiectasis,24001,410,0.77 [0.62-0.96],0.0175384668466884
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23661,70,1.07 [0.64-1.80],0.796602516054964
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26580,2989,0.84 [0.78-0.91],1.871445020339367e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26439,62,0.59 [0.34-1.04],0.0662068069693991
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic sinusitis,26525,148,0.85 [0.60-1.22],0.3824681794930227
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27565,1067,0.64 [0.56-0.73],3.909496761916355e-11
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Deviated nasal septum,26450,73,1.02 [0.62-1.70],0.9300753622886242
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25624,5203,0.94 [0.88-0.99],0.0323815776401204
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26712,335,0.87 [0.69-1.10],0.2449358045533582
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Early onset COPD,26820,322,0.71 [0.56-0.90],0.0051033283993931
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Emphysema,23869,278,0.47 [0.36-0.61],7.270045029699816e-09
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26090,235,0.73 [0.55-0.97],0.0312568922191286
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27546,1674,0.97 [0.88-1.08],0.618105326653801
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Interstitial lung disease,26131,276,0.85 [0.66-1.10],0.2124766590688851
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Later onset COPD,26811,745,0.62 [0.53-0.72],2.155180966106425e-09
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27735,234,1.19 [0.90-1.56],0.2239660568289633
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Nasal polyp,26446,69,1.18 [0.70-1.99],0.5303656927314777
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27510,929,0.92 [0.80-1.05],0.2203174251777542
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of pleura,27549,1769,0.98 [0.88-1.08],0.6547962153351793
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27173,796,0.83 [0.71-0.96],0.0153781148920501
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other pleural conditions,25815,35,0.40 [0.19-0.84],0.0159766335042298
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27660,349,1.09 [0.87-1.37],0.4364625968225204
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27652,1192,0.87 [0.77-0.99],0.0325980407048655
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pleural effusion,26638,858,1.10 [0.95-1.27],0.2197404804632796
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pleural plaque,25827,47,0.37 [0.20-0.71],0.0026636926020874
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27314,1442,0.95 [0.84-1.06],0.3248310496003445
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27705,204,1.22 [0.91-1.63],0.1874363349633166
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pneumothorax,25872,92,0.72 [0.46-1.13],0.1490081388099858
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pollen allergy,27709,242,0.85 [0.64-1.12],0.2439432395367681
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pulmonary oedema,27373,62,2.60 [1.64-4.10],4.226433304285367e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19645,53,0.53 [0.28-0.99],0.0479837467429009
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27485,904,0.92 [0.80-1.06],0.237164498413902
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26667,290,0.91 [0.70-1.17],0.4596829758237599
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Viral pneumonia,26086,214,0.91 [0.68-1.22],0.5474849874883325
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27333,167,0.96 [0.69-1.33],0.8130519750542267
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13400,109,0.83 [0.54-1.28],0.4004062717263362
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19754,37,1.65 [0.82-3.31],0.1606043872377034
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute appendicitis,27554,144,0.87 [0.60-1.26],0.4670110759631639
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute gastritis,20801,91,1.21 [0.76-1.91],0.4272151816125029
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute pancreatitis,25410,164,1.19 [0.85-1.66],0.3021258378881344
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute peritonitis,27151,89,2.11 [1.38-3.24],0.0006184435834853
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Alcoholic liver disease,26848,34,0.49 [0.23-1.05],0.0654192978507825
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Barrett oesophagus,21054,344,1.00 [0.78-1.26],0.971311750436258
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",25326,80,1.34 [0.84-2.15],0.2155329654185372
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27307,80,1.32 [0.83-2.10],0.241114608598915
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholecystitis,25437,191,1.21 [0.89-1.65],0.2263664895451578
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholelithiasis,26447,1201,1.15 [1.02-1.30],0.0252076131399783
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Chronic gastritis,21055,345,1.08 [0.85-1.36],0.5375868884377203
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Chronic pancreatitis,25289,43,1.56 [0.82-2.97],0.178196471244754
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27657,74,1.13 [0.69-1.85],0.6147698935306091
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Coeliac disease,26162,154,1.15 [0.81-1.64],0.4297594919630084
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Collagenous colitis,25809,114,1.06 [0.71-1.60],0.7663181248241363
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27600,153,1.08 [0.76-1.53],0.6851934309702745
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Constipation,27391,1748,0.95 [0.86-1.06],0.3800964931349874
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn disease,25790,95,1.28 [0.83-2.00],0.2663100778107763
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27380,73,1.21 [0.73-2.00],0.4531937720433164
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25794,99,1.29 [0.83-1.98],0.2553701131741259
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Dental caries,26904,235,0.77 [0.58-1.03],0.0745995367388471
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26106,2502,1.05 [0.96-1.14],0.2805208434471838
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of appendix,27597,187,0.78 [0.56-1.07],0.1263843371827464
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of liver,27642,828,0.97 [0.84-1.13],0.725529394467535
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",25417,4707,1.00 [0.94-1.06],0.9139466804905234
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27269,600,0.98 [0.83-1.17],0.8575057536774879
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27618,556,1.36 [1.14-1.63],0.0007630881879289
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26789,120,1.31 [0.89-1.93],0.1659431375765679
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26633,66,0.91 [0.54-1.53],0.7130469634952001
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27438,1430,1.00 [0.89-1.11],0.9313774918328064
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of tongue,26645,112,0.99 [0.65-1.49],0.9531503965723178
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26864,1618,1.14 [1.02-1.26],0.0191434781672891
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,22969,3252,0.98 [0.91-1.06],0.5682989137059076
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Duodenal ulcer,20842,132,1.05 [0.72-1.53],0.7915148483629378
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27691,111,1.00 [0.67-1.50],0.9946172149654122
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27639,62,1.03 [0.58-1.81],0.9273994486437548
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,26910,96,1.10 [0.71-1.70],0.6652778281190332
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19832,115,1.25 [0.83-1.88],0.2924759529184283
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Functional dyspepsia,21376,666,0.83 [0.70-0.98],0.0288394651646811
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastric ulcer,21061,351,0.99 [0.79-1.25],0.932376968281314
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23549,2839,0.95 [0.88-1.03],0.2258275301079916
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21186,476,0.99 [0.81-1.20],0.9056961707504634
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21695,8593,1.02 [0.98-1.07],0.3270884569823459
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,GI-bleeding,27163,1155,0.97 [0.85-1.10],0.6086698872697784
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26733,64,1.16 [0.68-1.98],0.5794490961159294
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20704,1281,0.97 [0.86-1.10],0.6357698648061163
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",26854,40,0.88 [0.45-1.73],0.7206942815685022
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Hernia,26547,2943,1.03 [0.95-1.12],0.4514455510399855
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Impacted teeth,27650,57,0.96 [0.53-1.73],0.8920635916979252
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Impaction of intestines,19781,64,1.20 [0.69-2.06],0.5172105923920487
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Inguinal hernia,23774,170,0.74 [0.53-1.04],0.0851883463764487
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,19821,104,1.06 [0.69-1.62],0.7833731744208202
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26189,181,1.17 [0.85-1.61],0.3418850430715754
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20549,832,1.16 [1.00-1.35],0.0580095261830992
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27726,365,1.02 [0.82-1.28],0.853598661783366
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26532,837,1.17 [1.01-1.35],0.0414648542116939
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26822,1127,1.11 [0.97-1.26],0.119531796058565
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20872,162,1.02 [0.72-1.44],0.9276256761674788
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophagitis,21287,577,1.04 [0.86-1.24],0.6992767606542974
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27695,162,0.99 [0.71-1.39],0.962335793183857
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23664,60,0.97 [0.55-1.70],0.9109306861132443
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,21005,1288,0.95 [0.84-1.07],0.37653558577927
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25551,305,1.20 [0.94-1.54],0.1336676446421454
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,25436,190,1.09 [0.80-1.50],0.5710607739244886
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestine,21334,1617,1.01 [0.91-1.13],0.8316851033512456
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestines,25528,5811,1.02 [0.96-1.08],0.5961042558128282
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26638,237,0.91 [0.69-1.21],0.5078246731497067
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of liver,27509,695,1.01 [0.86-1.18],0.9381368305541338
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,21301,591,1.00 [0.83-1.19],0.9727913228231054
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of pancreas,25408,162,1.41 [1.01-1.96],0.0415873441599292
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27553,491,1.31 [1.08-1.59],0.0056965227169263
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21809,1099,1.05 [0.92-1.20],0.469065843476917
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27182,1174,0.96 [0.85-1.09],0.5439908109161437
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26868,199,0.86 [0.64-1.17],0.347360820626145
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21522,1805,0.95 [0.86-1.06],0.3703784686372805
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22855,2145,1.06 [0.97-1.17],0.2090301876143031
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,26917,103,1.12 [0.73-1.71],0.5985950997874885
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26684,989,1.15 [1.00-1.32],0.0434730734696803
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",20049,332,1.14 [0.90-1.45],0.2808664143436956
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27629,72,1.10 [0.65-1.87],0.7159361062312997
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,20217,500,1.05 [0.86-1.27],0.6375783554229827
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26141,133,1.40 [0.97-2.02],0.069332962147633
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27734,69,1.17 [0.70-1.96],0.5569146983554998
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26671,129,1.01 [0.69-1.47],0.972822592352655
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Toxic colitis,25762,67,1.14 [0.68-1.94],0.6176544357942846
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20947,237,0.96 [0.72-1.27],0.7615419829866829
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcerative colitis,25864,169,0.86 [0.62-1.20],0.3840352089922419
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25835,140,0.89 [0.62-1.29],0.5432010651963517
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Umbilical hernia,23775,171,0.77 [0.55-1.08],0.125524848778447
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,19911,194,1.04 [0.77-1.42],0.7848381860713906
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ventral hernia,23865,261,0.89 [0.68-1.16],0.3926395427461115
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Volvulus,19805,88,0.60 [0.38-0.96],0.031954357297304
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27653,263,1.06 [0.81-1.39],0.6729902793736579
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27417,77,0.71 [0.43-1.17],0.1792995561837691
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25649,224,1.10 [0.82-1.47],0.5252335123382299
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27203,643,1.23 [1.04-1.46],0.0136477745753667
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26707,147,1.16 [0.81-1.64],0.4210942550888965
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,25771,346,0.99 [0.79-1.25],0.9400312737562916
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27424,285,1.02 [0.79-1.31],0.9000888476053843
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27632,493,1.16 [0.95-1.40],0.1393889071517992
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27191,52,1.25 [0.69-2.27],0.4655314170507489
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26120,3216,1.00 [0.92-1.07],0.9058966036399344
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27283,486,1.01 [0.83-1.23],0.8907128956240401
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27131,334,1.02 [0.81-1.30],0.8434209612658359
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27418,858,1.15 [0.99-1.32],0.0664109266035064
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27718,79,0.75 [0.46-1.24],0.2627347496385488
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,25516,91,0.53 [0.34-0.84],0.0066089518192084
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26843,46,0.70 [0.37-1.32],0.2747800754922429
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27409,270,1.03 [0.79-1.34],0.8133865278558843
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25847,422,0.85 [0.69-1.06],0.1471363212332291
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,25474,49,1.00 [0.54-1.87],0.9967920076849376
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27634,83,1.71 [1.10-2.67],0.0180606513792102
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26717,157,0.86 [0.61-1.22],0.4104160337546013
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27509,169,0.79 [0.57-1.11],0.1737021403026171
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27197,58,1.56 [0.91-2.67],0.1070151943090396
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,25492,67,0.76 [0.44-1.30],0.3148144965329983
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27048,1623,0.93 [0.84-1.04],0.2006200243212996
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25882,457,0.86 [0.70-1.06],0.1556437315173135
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,25479,54,1.03 [0.57-1.87],0.924521864945134
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27655,315,0.82 [0.64-1.04],0.1049554630859484
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27225,86,1.51 [0.97-2.36],0.0707694207902805
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27580,240,0.80 [0.61-1.06],0.1225071129853173
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27689,299,1.03 [0.80-1.33],0.7955445272568105
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25587,162,1.02 [0.72-1.44],0.9175211765989156
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25692,267,1.17 [0.90-1.53],0.2512352234913485
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27674,284,1.04 [0.80-1.35],0.7725630665942325
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25630,205,1.01 [0.75-1.35],0.964569729727471
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27705,154,1.46 [1.04-2.05],0.0288954932178616
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23677,126,0.81 [0.55-1.20],0.2949738616352378
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25187,6466,0.95 [0.90-1.01],0.0943062956597988
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,23773,5052,0.93 [0.87-0.99],0.0185072864315775
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23631,80,1.22 [0.75-1.99],0.4124243327807215
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23790,154,0.85 [0.60-1.21],0.3761206274859894
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23850,214,1.07 [0.80-1.44],0.6509370953769472
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27446,114,0.96 [0.65-1.43],0.8488990943601921
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",23755,119,0.71 [0.47-1.06],0.0928080566071675
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,20112,1391,0.96 [0.86-1.08],0.531988661371724
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27588,220,1.03 [0.77-1.38],0.8176613601778903
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24256,620,0.80 [0.67-0.95],0.0128957426830074
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,23317,8221,0.93 [0.89-0.98],0.0040155355491095
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24853,143,0.89 [0.62-1.28],0.5439891746559118
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23688,137,0.85 [0.59-1.23],0.3851670290296716
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24244,693,0.86 [0.73-1.02],0.0761769283252182
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26713,3077,0.92 [0.85-1.00],0.0417130830244767
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23728,177,1.00 [0.72-1.39],0.9913719763534744
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,23938,387,1.16 [0.93-1.44],0.1916107902878301
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23723,172,1.01 [0.72-1.41],0.9507806239850832
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,26774,106,1.05 [0.69-1.59],0.8313143707757343
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20621,1900,0.89 [0.81-0.99],0.025572607359492
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18951,230,1.61 [1.23-2.11],0.0005281075291908
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27729,227,1.66 [1.26-2.17],0.0002521174078262
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18823,102,0.68 [0.44-1.05],0.0827650023434991
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19294,573,0.93 [0.77-1.11],0.4140654077441433
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23883,332,0.78 [0.61-0.99],0.0405767297562745
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19363,642,0.91 [0.77-1.08],0.2851252879514142
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23703,67,1.35 [0.80-2.28],0.2574264373436166
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24361,725,0.94 [0.80-1.10],0.4123683772022934
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23971,335,0.91 [0.72-1.16],0.4550259984037433
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19319,598,0.88 [0.73-1.05],0.1453878970996569
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23645,94,1.38 [0.88-2.14],0.1569505397706116
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23621,70,1.12 [0.67-1.88],0.6665471315379137
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,24759,49,0.80 [0.43-1.49],0.4748155921407745
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27251,2541,0.90 [0.82-0.98],0.0143400429053853
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26537,1827,0.90 [0.81-0.99],0.0375005763060091
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27543,609,0.95 [0.80-1.13],0.5756635918986238
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21813,3092,0.92 [0.85-0.99],0.0277744558629438
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18795,74,0.92 [0.55-1.53],0.7364423197365452
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23656,105,1.07 [0.70-1.62],0.763909501635249
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18765,44,1.64 [0.87-3.10],0.1246404338918198
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18927,206,0.85 [0.63-1.16],0.3143095231914254
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,25004,294,1.00 [0.78-1.28],0.986718701157686
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,25304,594,0.85 [0.71-1.02],0.0814212244776316
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27711,113,1.13 [0.76-1.70],0.5444013820954052
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25714,2078,0.96 [0.87-1.06],0.395942991144703
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23684,133,1.00 [0.68-1.46],0.9964191695385044
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18952,231,1.08 [0.81-1.44],0.5845050663890413
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24461,825,0.97 [0.84-1.13],0.7147723768734533
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,21296,2575,0.95 [0.87-1.04],0.2775895028670068
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,26800,132,0.96 [0.66-1.40],0.8438889442683524
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27724,76,0.65 [0.40-1.08],0.0977410299003182
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23633,82,1.23 [0.77-1.96],0.3890524255753341
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25062,1511,1.04 [0.93-1.16],0.5261942237152613
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23636,85,1.10 [0.69-1.75],0.6901912407007635
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20741,2020,0.97 [0.88-1.07],0.5478695578627368
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24847,137,0.93 [0.64-1.34],0.6796384364259231
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23614,63,0.49 [0.28-0.85],0.0119813618977149
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,23843,207,1.16 [0.86-1.57],0.3243464083661906
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24155,604,1.04 [0.88-1.24],0.6303211807131519
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27180,512,0.92 [0.76-1.11],0.3882808647173827
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24293,657,1.15 [0.97-1.35],0.1032804709253017
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27557,589,0.95 [0.79-1.13],0.5358605876136036
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27713,70,0.97 [0.58-1.63],0.9186335677154576
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23776,225,0.95 [0.71-1.27],0.717828834240942
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,21276,935,1.12 [0.97-1.29],0.1130608943963828
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24227,676,1.01 [0.86-1.19],0.9070718295633812
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23673,122,0.82 [0.55-1.22],0.3325938602688968
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18797,76,1.20 [0.73-1.96],0.4680366855794232
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21405,2684,0.97 [0.89-1.05],0.4183406774185809
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19582,861,0.84 [0.73-0.98],0.0253299563733924
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,26965,297,0.97 [0.75-1.25],0.8166658605762135
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27684,86,1.17 [0.74-1.87],0.5006530099742006
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",25409,57,0.96 [0.55-1.67],0.8861059943594277
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18798,77,0.64 [0.38-1.05],0.0794530567966326
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,23748,112,0.78 [0.52-1.19],0.2520022378384329
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19333,612,0.92 [0.78-1.10],0.3701684224312409
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23892,341,0.92 [0.73-1.17],0.4966073477688481
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23928,292,1.00 [0.78-1.29],0.9764957865714092
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,23920,284,0.69 [0.53-0.89],0.0050855333298503
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,21414,85,1.02 [0.64-1.62],0.9461967056956644
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27719,76,0.97 [0.59-1.60],0.9180298591726253
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24197,646,0.85 [0.72-1.01],0.0631022860272883
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],26834,166,1.12 [0.80-1.56],0.5123991489847337
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26414,2863,0.95 [0.88-1.03],0.2232788582503589
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23705,154,0.77 [0.54-1.10],0.1532925559444688
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24220,584,0.89 [0.74-1.07],0.2070528156322251
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26000,273,1.00 [0.77-1.29],0.9782060615241066
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,23923,287,0.88 [0.68-1.14],0.3266584323423669
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25425,1789,0.94 [0.85-1.04],0.2366241686926671
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24846,1210,0.94 [0.83-1.06],0.322613882641931
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23618,67,1.23 [0.73-2.05],0.4366912375132975
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26896,228,0.88 [0.66-1.17],0.3696330221029018
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23758,207,0.89 [0.65-1.20],0.4439473856418392
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23678,127,0.81 [0.55-1.20],0.2954740817282577
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18774,53,1.17 [0.65-2.10],0.6124612584468063
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26645,1280,1.43 [1.27-1.61],2.9491743088115317e-09
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20771,102,0.89 [0.58-1.38],0.6037370899853185
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27026,111,1.10 [0.73-1.67],0.6374731256584596
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27578,239,1.19 [0.90-1.57],0.2133950639319611
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27367,28,0.82 [0.35-1.89],0.6383025103902449
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26880,1515,2.50 [2.25-2.78],4.545457435711671e-64
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27563,82,4.12 [2.92-5.82],7.48420634116324e-16
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27529,248,1.37 [1.05-1.79],0.0221840703032462
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Cystitis,24466,256,1.13 [0.86-1.48],0.3701796256291401
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Dialysis,25420,55,10.87 [6.84-17.28],6.143775504895527e-24
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27258,343,0.94 [0.74-1.18],0.5768859589772204
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Endometriosis,20850,181,0.81 [0.58-1.12],0.2059360974948715
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21070,401,0.87 [0.69-1.09],0.2198799669539209
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21688,1019,0.88 [0.76-1.01],0.0599064232245577
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21591,5138,1.09 [1.02-1.16],0.0061421484525266
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27546,65,1.81 [1.10-2.97],0.0193814199848627
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,25242,215,0.90 [0.67-1.22],0.4997964388384472
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27186,403,0.88 [0.71-1.09],0.2419221983248415
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Irregular menses,27269,129,0.93 [0.63-1.37],0.7042349532240822
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20977,308,0.88 [0.69-1.14],0.3454801267062596
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24287,77,1.07 [0.65-1.75],0.7954003026785059
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23149,2480,0.88 [0.80-0.96],0.0038731361728641
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20808,139,1.16 [0.80-1.67],0.4418244490476456
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27728,68,1.45 [0.87-2.41],0.1538220146668418
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27731,76,0.92 [0.56-1.50],0.7350995195598016
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26477,2267,1.06 [0.96-1.16],0.2412463128222123
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24692,482,0.92 [0.75-1.12],0.4041331228078436
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27036,121,0.84 [0.56-1.24],0.3805727785180681
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27677,396,1.63 [1.32-2.00],4.9698295737762615e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27681,92,0.90 [0.57-1.41],0.6335736908077889
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26152,1942,1.06 [0.96-1.17],0.2204144789907628
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26991,208,1.03 [0.76-1.39],0.8506227256911243
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20827,158,0.85 [0.60-1.20],0.3488578731983148
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21041,372,0.92 [0.74-1.15],0.4733825588016942
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20780,111,0.67 [0.44-1.02],0.0645271524547303
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20880,211,0.83 [0.61-1.12],0.2121063019229418
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25293,266,1.12 [0.85-1.47],0.4152797006241037
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27408,127,1.76 [1.23-2.53],0.0022146191082186
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20977,308,0.91 [0.71-1.16],0.438194213447494
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20775,106,0.59 [0.38-0.91],0.0165064997791174
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21321,652,0.95 [0.80-1.13],0.5667887061597061
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20831,162,0.68 [0.48-0.95],0.0262900497185952
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21271,602,1.06 [0.89-1.27],0.4894955655008061
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27520,39,3.18 [1.83-5.52],4.075026134690996e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27542,2515,1.63 [1.50-1.78],7.983368175975947e-30
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",25192,165,1.33 [0.94-1.86],0.1042996957814435
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25470,105,3.53 [2.36-5.29],9.600690965131995e-10
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27374,35,1.48 [0.73-3.01],0.2747744550587695
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24358,148,1.12 [0.78-1.59],0.5451505809521182
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27613,274,1.20 [0.93-1.55],0.1637434654487644
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20812,143,1.04 [0.72-1.50],0.8380168467302266
